Eli Lilly and Company (LLY) closed at $1,281.52 on October 28, 2026, a gain of 0.18% over the prior 24-hour period. The modest daily advance came as the pharmaceutical giant continued to trade near elevated levels following a substantial run-up over the past month.
Over the trailing 30 days, LLY has risen 8.21%, reflecting sustained buying interest in the stock. However, the seven-day window tells a slightly softer story, with shares down 0.26% over that shorter stretch, suggesting some near-term consolidation after the broader monthly advance.
Eli Lilly's market capitalization stood at $1,140.17 billion as of the close, maintaining its position among the most valuable publicly traded companies. The stock's price and valuation figures reflect the scale the company has reached in the pharmaceutical sector.
The combination of a strong 30-day performance and a modest daily uptick indicates continued investor attention on LLY, while the slight weekly dip points to a degree of short-term choppiness within an otherwise positive month for the shares.
